Quemliclustat New
Data Sheet
For research use only. Not for human use.
| Size | Price | Stock | Quotation Inquiry |
|---|---|---|---|
| 20.00 mg | Get quote | In-stock | Quotation Inquiry |
| 100.00 mg | Get quote | In-stock | Quotation Inquiry |
Get Quotation Now* Required Fields.
Please complete the form below and you will get the price list in 1 minute.
* Required Fields.
Please complete the form below and we will contact you shortly.
* Required Fields.
Please complete the form below and we will contact you shortly.
| CAS No. | 2105904-82-1 | Cat. No. | BCP31923 |
| Name | Quemliclustat | ||
| Synonyms | AB 680; AB680;AB-680; | ||
| SMILES | CC(C1=CC=CC=C1F)NC2=CC(=NC3=C2C=NN3C4C(C(C(O4)COP(=O)(CP(=O)(O)O)O)O)O)Cl | ||
| Chemical Name | |||
| Formula | C20H24ClFN4O9P2 | M. Wt | 580.82 |
| Purity | 98% | Storage | Store at 4-8°C |
| Description | Quemliclustat is a small molecule, competitive inhibitor of the ectoenzyme CD73 (cluster of differentiation 73; 5'-ecto-nucleotidase; 5'-NT; ecto-5'-nucleotidase), with potential immunomodulating and antineoplastic activities. Upon administration, quemliclustat targets and binds to CD73, leading to clustering of and internalization of CD73. This prevents CD73-mediated conversion of adenosine monophosphate (AMP) to adenosine and decreases the amount of free adenosine in the tumor microenvironment (TME). This prevents adenosine-mediated lymphocyte suppression and increases the activity of CD8-positive effector cells and natural killer (NK) cells. This also activates macrophages and reduces the activity of myeloid-derived suppressor cells (MDSCs) and regulatory T-lymphocytes (Tregs). By abrogating the inhibitory effect on the immune system and enhancing the cytotoxic T-cell-mediated immune response against cancer cells, tumor cell growth decreases. In addition, clustering and internalization of CD73 decreases the migration of cancer cells and prevents metastasis. CD73, a plasma membrane protein belonging to the 5'-nucleotidase (NTase) family, upregulated on a number of cancer cell types, catalyzes the conversion of extracellular nucleotides, such as AMP, to membrane-permeable nucleosides, such as adenosine; it plays a key role in adenosine-mediated immunosuppression within the TME. | ||
Recommend Products
More >
-
β-Cyclodextrin
Cat. No.：BCP49653
No.：7585-39-9
Product Details -
α-Cyclodextrine
Cat. No.：BCP49652
No.：10016-20-3
Product Details -
-
H-Gly-hyp-ala-OH
Cat. No.：BCP49639
No.：62147-09-5
Product Details -
Cyanine 7 maleimide
Cat. No.：BCP49636
No.：2120392-49-4
Product Details -
Flavin adenine dinucleotide
Cat. No.：BCP49621
No.：146-14-5
Product Details -
-
-
-
Onilcamotide
Cat. No.：BCP49539
No.：1164096-85-8
Product Details -
-
Delandistrogene Moxeparvovec
Cat. No.：BCP49536
No.：2305040-16-6
Product Details -
PF-06928316
Cat. No.：BCP49533
No.：PF-06928316
Product Details -
-
-
-
Vutrisiran
Cat. No.：BCP45179
No.：1867157-35-4
Product Details -
-
Tosylate-DPA-714
Cat. No.：BCP39586
No.：958233-17-5
Product Details -
Coelenterazine H
Cat. No.：BCP10701
No.：50909-86-9
Product Details
Tags:Quemliclustat supplier,Quemliclustat purchase,Quemliclustat manufacturer,Quemliclustat distributor,Quemliclustat cost,Quemliclustat buy,Quemliclustat for sale